Breast Antibody
Breast Antibody
 Breast cancer with breast tissue array |
|||
| BR246d | TissueArray | each | 66 EUR |
|
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 12 cases/24 cores, replacing BR246c |
|||
Breast cancer with breast tissue array |
|||
| BR482 | TissueArray | each | 198 EUR |
|
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores |
|||
Breast cancer with breast tissue array |
|||
| BR720 | TissueArray | each | 270 EUR |
|
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical satge (reference AJCC 7th version), 72 cases/72 cores |
|||
Breast cancer with breast tissue array |
|||
| T087d | TissueArray | each | 66 EUR |
|
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T087c |
|||
Breast cancer with breast tissue array |
|||
| T088d | TissueArray | each | 66 EUR |
|
Description: Breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T088c |
|||
 Breast Tumor Kinase antibody |
|||
| 70R-31875 | Fitzgerald | 100 ug | 392.4 EUR |
|
Description: Rabbit polyclonal Breast Tumor Kinase antibody |
|||
Breast Tumor Kinase antibody |
|||
| 70R-33385 | Fitzgerald | 100 ug | 392.4 EUR |
|
Description: Rabbit polyclonal Breast Tumor Kinase antibody |
|||
) BRCA1 Antibody (Breast Marker) |
|||
| R32718 | NSJ Bioreagents | 100ug | 419 EUR |
BRCA1 Antibody (Breast Marker) |
|||
| V8101-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V8101-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V8101SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V8102-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V8102-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V8102SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: This gene encodes a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V3239-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BRCA1 (Breast cancer type 1 susceptibility protein) is a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V3239-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: BRCA1 (Breast cancer type 1 susceptibility protein) is a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V3239SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BRCA1 (Breast cancer type 1 susceptibility protein) is a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V3240-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BRCA1 (Breast cancer type 1 susceptibility protein) is a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V3240-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: BRCA1 (Breast cancer type 1 susceptibility protein) is a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
BRCA1 Antibody (Breast Marker) |
|||
| V3240SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BRCA1 (Breast cancer type 1 susceptibility protein) is a nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. |
|||
 Breast cancer |
|||
| BR1008b | TissueArray | each | 306 EUR |
|
Description: Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result, 100 cases/100 cores, replacing BR1008a |
|||
Breast cancer |
|||
| BR724 | TissueArray | each | 270 EUR |
|
Description: Breast cancer, adjacent and adjacent normal tissue array, 66 cases/72 cores |
|||
Breast cancer |
|||
| BR725 | TissueArray | each | 270 EUR |
|
Description: Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores |
|||
 Multiple breast cancer with breast tissue array |
|||
| BR087e | TissueArray | each | 48 EUR |
|
Description: Multiple breast cancer with breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR087d |
|||
 Breast cancer with matched breast tissue array |
|||
| BR251e | TissueArray | each | 60 EUR |
|
Description: Breast cancer with matched breast tissue array, including pathology grade, IHC info (ER,PR,Her-2,Ki67),TNM\Stage, 6 cases/24 cores (core size 1.5mm), replacing BR251d |
|||
 Breast carcinoma with matched breast tissue array |
|||
| BR251f | TissueArray | each | 60 EUR |
|
Description: Breast carcinoma with matched breast tissue array, including pathology grade, IHC info(ER\PR\Her-2\Ki67), TNM\Sstage, 6 cases/24 cores (core size 1.5mm), replacing BR251e |
|||
) Breast Tumor Kinase antibody (Tyr447) |
|||
| 70R-33384 | Fitzgerald | 100 ug | 392.4 EUR |
|
Description: Rabbit polyclonal Breast Tumor Kinase antibody (Tyr447) |
|||
 Breast cancer with cancer adjacent breast tissue array |
|||
| BC081116e | TissueArray | each | 306 EUR |
|
Description: Breast cancer with cancer adjacent breast tissue array, including invasive carcinoma of no special type, breast carcinoma with apocrine differentiation and AT tissue,pat hology grade, IHC (ER/PR/Her-2/Ki67) info, TNM/Stage (AJCC 7th edition), 107 cases/110 cores (core size 1.5mm), replacing BC081116d |
|||
 Breast cancer with adjacent normal breast tissue array |
|||
| BR1921c | TissueArray | each | 546 EUR |
|
Description: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR and Her-2), 189 cases/192 cores, replacing BR1921b |
|||
 tissue array) Breast disease spectrum (breast cancer progression) tissue array |
|||
| BR2082c | TissueArray | each | 546 EUR |
|
Description: Breast disease spectrum (breast cancer progression) tissue array, including pathology grade, TNM and clinical stage, IHC marker (ER, PR, HER2 and Ki-67), 186 cases/192 cores, replacing BR2082b |
|||
Breast cancer with adjacent normal breast tissue array |
|||
| BR803c | TissueArray | each | 258 EUR |
|
Description: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BR803b |
|||
Breast cancer with adjacent normal breast tissue array |
|||
| BR901a | TissueArray | each | 270 EUR |
|
Description: Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 45 cases/90 cores, replacing BR901 |
|||
 Breast normal tissue with breast cancer tissue array |
|||
| BRN801c | TissueArray | each | 270 EUR |
|
Description: Breast normal tissue with breast cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing BRN801b |
|||
 Human Breast CAFs |
|||
| CAF06 | Neuromics | 1,000,000 cells | 3278.4 EUR |
 Breast Membrane Lysate |
|||
| XBL-10496 | ProSci | 0.1 mg | 619.8 EUR |
|
Description: Human breast tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human breast tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated breast tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated breast tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
 Breast cancer TMA |
|||
| BR602 | TissueArray | each | 270 EUR |
|
Description: Breast cancer TMA, 3 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 57 cases/60 cores (Core Size 1.5mm), recent tear collections |
|||
 Breast tissue array |
|||
| BRN04a | TissueArray | each | 114 EUR |
|
Description: Breast tissue array, 4 cases/4 cores (2.0mm), replacing BRN04 |
|||
 Paraffin Tissue Section - Human Breast Tumor: Male Breast Hyperplasia |
|||
| T2235086-4 | Biochain | 5 slides | 308.4 EUR |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|||
 Paraffin Tissue Section - Human Breast Tumor: Medullarycarcinoma of Breast |
|||
| T2235086-5 | Biochain | 5 slides | 308.4 EUR |
|
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
|||
 and Breast Normal Adjacent Tissue TMA) Breast Hyperplasia (NAT) and Breast Normal Adjacent Tissue TMA |
|||
| BN08111a | TissueArray | each | 198 EUR |
|
Description: Breast Hyperplasia (NAT) and Breast Normal Adjacent Tissue TMA, 10 cases/30 cores (1.5mm), replacing BN08111 |
|||
 Advanced stage breast cancer and normal breast tissue array |
|||
| BR1191 | TissueArray | each | 306 EUR |
|
Description: Advanced stage breast cancer and normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), ER\PR\HER-2\Ki-67 marker, 119 cases/119 cores, (1.5mm) |
|||
 Breast cancer tissue array with adjacent normal breast tissue |
|||
| BR8011a | TissueArray | each | 306 EUR |
|
Description: Breast cancer tissue array with adjacent normal breast tissue, including TNM, clinical stage, pathology grade and DCIS, 80 cases/80 cores, replacing BR8011 |
|||
 Breast cancer with matched or unmatched breast tissue array |
|||
| BR802c | TissueArray | each | 270 EUR |
|
Description: Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 53 cases/80 cores, replacing BR802b |
|||
 Breast cancer with matched cancer adjacent breast tissue array |
|||
| BR804b | TissueArray | each | 306 EUR |
|
Description: Breast cancer with matched cancer adjacent breast tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2 and Ki67), 40 cases/80 cores, replacing BR804a |
|||
 with adjacent normal breast tissue array) Breast cancer (including one case of male breast cancer) with adjacent normal breast tissue array |
|||
| BC081120g | TissueArray | each | 306 EUR |
|
Description: Breast cancer (including one case of male breast cancer) with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage (AJCC 7th edition) with IHC results ER/PR/Her2/Ki67,110 cases/110 cores (core size 1.0 mm), replacing BC081120f |
|||
 (BRCA1/1398) Antibody) BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC941398-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF594 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC941398-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF594 conjugate, Concentration: 0.1mg/mL |
|||
 (BRCA1/1472) Antibody) BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC941472-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF594 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC941472-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF594 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNCA1398-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),APC conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNCA1472-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),APC conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC551398-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF555 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC551398-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF555 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC551472-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF555 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC551472-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF555 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC611398-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF660R conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC611398-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF660R conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC611472-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF660R conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC611472-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF660R conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNUM1398-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398), 1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNUM1472-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472), 1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNCP1398-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),PerCP conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNCP1472-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),PerCP conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNCR1398-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),RPE conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNCR1472-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),RPE conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC431398-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF543 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC431398-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF543 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC431472-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF543 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC431472-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF543 conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC051398-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF405M conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1398) Antibody |
|||
| BNC051398-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1398),CF405M conjugate, Concentration: 0.1mg/mL |
|||
BRCA1 (Breast Marker) (BRCA1/1472) Antibody |
|||
| BNC051472-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against BRCA1 (Breast Marker) (BRCA1/1472),CF405M conjugate, Concentration: 0.1mg/mL |
|||